Scholar rock reports new employee inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass.--(business wire)--scholar rock (nasdaq: srrk; the “company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 371,500 shares of its common stock to eleven newly hired employees, consisting of inducement stock options to.
NDAQ Ratings Summary
NDAQ Quant Ranking